Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,470.00
+33.60 (0.98%)
Jul 31, 2026, 3:30 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 432.76 billion as of July 31, 2026. Its market cap has increased by 23.74% in one year.
Market Cap
432.76B
Enterprise Value
428.72B
Revenue
57.76B
Ranking
n/a
PE Ratio
38.16
Stock Price
3,470.00
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 432.76B, an increase of 76,387.17%. That is a compound annual growth rate of 31.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 432.76B | 25.15% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mankind Pharma | 1.02T |
| Laurus Labs | 980.49B |
| Aurobindo Pharma | 909.21B |
| Alkem Laboratories | 687.68B |
| Glenmark Pharmaceuticals | 630.41B |
| Ipca Laboratories | 443.42B |
| Gland Pharma | 412.37B |
| Emcure Pharmaceuticals | 371.61B |